Published • loading... • Updated
Government and PP Agree to Opacate the Price of the Drug in the Face of the Trump Effect
Summary by redaccionmedica.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Hours after Mónica García claimed a common strategy in Europe to cushion the impact on drug prices of the Most Favored Nation (MNF) clause promoted by Donald Trump in 2025, the government agreed with the PP a key measure to establish a national basis in this regard: to strengthen confidentiality on pricing and financing agreements so as to protect access to therapeutic innovation in Spain. It was a week ago, when the Minister of Health attended …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
